MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Extended phenotypes of autosomal recessive cerebellar ataxia type 1: learn from a novel mutation of SYNE1 gene

    TL. Lee, CY. Chien, YT. Sun (Tainan, Taiwan)

    Objective: Mutations in the synaptic nuclear envelope protein 1 (SYNE1) gene have been reported to cause ARCA type 1 with a remarkable heterogeneity in clinical…
  • 2023 International Congress

    Parkinson’s disease-specific cortical atrophy as an independent contributor to motor symptom in Parkinson’s disease

    SW. Kang, HS. Yoo, CL. Lyoo (Seoul, Republic of Korea)

    Objective: In this study, we identified specific pattern of cortical atrophy in Parkinson's disease (PD) and investigated whether PD-specific cortical atrophy contributed to motor symptom,…
  • 2023 International Congress

    Clinical accuracy of Medtronic’s Percept built in longevity estimate algorithm following device exchange.

    E. Hargreaves, D. Caputo, D. Dolce, R. Dipaola, S. Danish (Neptune, USA)

    Objective: To examine the accuracy of Medtronic’s Percept built in device longevity estimate. Background: In June of 2020 Medtronic received FDA approval for its Percept…
  • 2023 International Congress

    Clinical usefulness of tandem gait test for estimating gait and balance in de novo Parkinson’s disease

    JS. Park, HT. Kim, SH. Lim (Busan, Republic of Korea)

    Objective: The purpose of this study is to objectively evaluate the gait and balance in patients with Parkinson’s disease showing abnormal tandem gait, using three-dimensional motion analysis.…
  • 2023 International Congress

    Modeling Parkinson’s disease progression accounting for the effect of symptomatic treatments in the Parkinson’s Progression Markers Initiative study

    B. Ribba, T. Simuni, K. Marek, A. Siderowf, L. Chahine, C. Diack, A. Monnet, B. Ricci, T. Nikolcheva, G. Pagano (Basel, Switzerland)

    Objective: To explore the natural history of Parkinson’s disease (PD) accounting for the effect of symptomatic treatments on progression by modeling the time course of…
  • 2023 International Congress

    Anle138b-P1-02: A randomised, double-blinded, placebo-controlled phase 1b study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of the oligomer modulator anle138b in Parkinson´s disease

    J. Levin, N. Singh, S. Melbourne, A. Morgan, C. Carroll, U. Fietzek, S. Ryazanov, A. Leonov, CH. Griesinger, F. Schmidt, D. Weckbecker, K. Prager, T. Matthias, A. Giese (Wendelsheim, Germany)

    Objective: To present first-in-patient data of the oligomer modulator anle138b (TEV-56286, emrusolmin) in patients with Parkinson’s disease (PD). Background: Synucleinopathies such as PD and Multiple…
  • 2023 International Congress

    Clinical characteristics of patients with dementia with Lewy bodies followed in a movement disorder clinic

    AS. Jakobsson, L. Salvesen, AM. Hejl (Copenhagen, Denmark)

    Objective: To describe the clinical phenotype of the subgroup of patients with Dementia with Lewy bodies (DLB) followed in a movement disorder setting rather than…
  • 2023 International Congress

    Asymmetry and the development of phase-specific deep brain stimulation for essential tremor

    S. He, A. Deli, T. West, F. Plazas, A. Pogosyan, C. Wiest, D. Herz, P. Andrade, V. Visser-Vandewalle, E. Pereira, A. Green, H. Tan, H. Cagnan (Oxford, United Kingdom)

    Objective: The main aim of the study was to investigate asymmetry in ET and the association between tremor asymmetry and the effect of DBS on…
  • 2023 International Congress

    Identification of a Metabolic Brain Pattern Specific to Corticobasal Degeneration and Its Utility in Differential Diagnosis

    T. Rus, J. Jamšek, M. Perovnik, M. Trošt (Ljubljana, Slovenia)

    Objective: To identify a metabolic brain pattern specific to corticobasal degeneration (CBD) and to develop a machine learning algorithm that can differentiate CBD from other…
  • 2023 International Congress

    Clinical and radiological factors associated with mortality in Parkinson’s disease

    G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, R. Luquin (Pamplona, Spain)

    Objective: To assess clinical and radiological risk factors of mortality in a cohort of patients with a clinical diagnosis of Parkinson’s disease (PD) according to…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley